You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HX008

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Beijing (OH2 injection, HX008 injection)

Recruiting
  • Melanoma
  • OH2 injection
  • HX008 injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jan 28, 2023

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors

Not yet recruiting
  • Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
  • HX008 + TACE
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer hospital
Dec 8, 2022

Advanced Solid Tumors Trial in Guangzhou, Changsha (MRG003+HX008)

Recruiting
  • Advanced Solid Tumors
  • Guangzhou, Guangdong, China
  • +1 more
Jan 15, 2023

Metastatic Colorectal Cancer Trial in China (HX008, Investigator's Choice Chemotherapy)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • HX008
  • Investigator's Choice Chemotherapy
  • Hefei, Anhui, China
  • +9 more
Dec 8, 2022

Advanced Malignant Solid Tumors Trial in Shanghai (MRG002+HX008)

Recruiting
  • Advanced Malignant Solid Tumors
  • Zhengzhou, Henan, China
  • +4 more
Nov 30, 2022

Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant

Not yet recruiting
  • Melanoma Stage IV
  • Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
  • +2 more
  • (no location specified)
Sep 27, 2021

Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant

Not yet recruiting
  • Melanoma Stage IV
  • Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
  • +2 more
  • (no location specified)
Sep 27, 2021

Advanced Solid Tumor Trial in Changsha, Wuhan (HX008)

Recruiting
  • Advanced Solid Tumor
  • HX008
  • Changsha, China
  • +2 more
Mar 28, 2021

Triple-negative Breast Cancer Trial in Shanghai (HX008+Cisplatin+Gemcitabine)

Unknown status
  • Triple-negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 8, 2021

Melanoma Trial in Beijing (HX008, LP002)

Unknown status
  • Melanoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 12, 2021

Bladder Cancer Trial in China (HX008)

Recruiting
  • Bladder Cancer
  • HX008
  • Wuhan, Hubei, China
  • +4 more
Jan 31, 2021

Melanoma Trial in China (HX008)

Active, not recruiting
  • Melanoma
  • HX008
  • Beijing, Beijing, China
  • +10 more
Feb 7, 2021

Nonsquamous NSCLC Trial in China (HX008, Pembrolizumab, pemetrexed)

Recruiting
  • Nonsquamous Non-small Cell Lung Cancer
  • HX008
  • +3 more
  • Hefei, Anhui, China
  • +9 more
Feb 7, 2021

Anaplastic Thyroid Cancer Trial in Beijing (HX008)

Not yet recruiting
  • Anaplastic Thyroid Cancer
  • HX008
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Oct 2, 2020

Hepatocellular Carcinoma Trial in China (HX008, Bevacizumab, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • HX008
  • +2 more
  • Hefei, Anhui, China
  • +12 more
Feb 2, 2021

Advanced Solid Tumor Trial in China (Anti-PD-1 mAb)

Active, not recruiting
  • Advanced Solid Tumor
  • Anti-PD-1 monoclonal antibody
  • Beijing, Beijing, China
  • +29 more
Mar 2, 2021

Stomach Cancer Trial in China (Irinotecan Hydrochloride Injection, HX008, Placebo)

Recruiting
  • Stomach Cancer
  • Irinotecan Hydrochloride Injection
  • +2 more
  • Hefei, Anhui, China
  • +63 more
Jan 26, 2021

Small Cell Lung Carcinoma Trial in Worldwide (Pembrolizumab/Vibostolimab Co-Formulation, Saline , Etoposide)

Recruiting
  • Small Cell Lung Carcinoma
  • Pembrolizumab/Vibostolimab Co-Formulation
  • +5 more
  • Los Angeles, California
  • +122 more
Jan 27, 2023

MBR + Suture Tape and Anatomic Reconstruction for CLAI in GJL

Recruiting
  • Ankle Sprains
  • Hypermobility Syndrome
  • Modified Broström + Suture tape augmentation operation
  • Anatomic reconstruction operation
  • Beijing, China
    Peking University Third Hospital
Jan 24, 2023

Subclinical Vertebral Fractures in Rheumatoid Arthritis and

Not yet recruiting
  • Vertebral Fracture
  • DEXA scan,X_ray
  • (no location specified)
Oct 16, 2023

Deep Sedation, Oxygen Therapy, Radiofrequency Ablation Trial (High flow nasal cannula)

Recruiting
  • Deep Sedation
  • +2 more
  • High flow nasal cannula
  • Maastricht, Netherlands
    Maastricht UMC
Dec 5, 2022

Papillary Thyroid Carcinoma Trial in Guangzhou (retro-auricular single-site endoscopic thyroidectomy, traditional open surgery

Recruiting
  • Papillary Thyroid Carcinoma
  • retro-auricular single-site endoscopic thyroidectomy
  • traditional open surgery thyroidectomy
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Apr 17, 2022

Advanced Solid Tumor Trial in Chongqing, Chengdu (ATG-008, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Chongqing, Chongqing, China
  • +1 more
May 13, 2021

Colorectal Tumors Trial in Gent (perioperative chemo plus bevacizumab, cytoreductive surgery, Intraperitoneal Oxaliplatin)

Active, not recruiting
  • Colorectal Neoplasms
  • perioperative chemotherapy plus bevacizumab
  • +2 more
  • Gent, Belgium
    Ghent University Hospital
Dec 12, 2022

Diagnosis, Axilla; Breast Trial in Ankara (Ultrasound and biyopsy)

Completed
  • Diagnosis
  • Axilla; Breast
  • Ultrasound and biyopsy
  • Ankara, Turkey
    Ankara Education and Research Hospital
Jun 25, 2023